Author

Charline Ogier

Fox Chase Cancer CenterORCID 0000-0002-4129-0433Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Debora Barbosa Vendramini CostaiD· 2 shared Edna CukiermaniD· 2 shared Janusz Franco‐BarrazaiD· 2 shared Jaye C. GardineriD· 2 shared Kathy Qi CaiiD· 2 shared Mark AndrakeiD· 2 shared Ralph FrancesconeiD· 2 shared Tiffany LuongiD· 2 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Debora Barbosa Vendramini CostaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyNature CancerPeer-reviewedOct 30, 2026

Trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer growth and immune suppression via phospholipid scramblase anoctamin 6 (ANO6).

Charline Ogier, Charles Solomon Akino Mercy, Elena Bondarenko…·Igor A. Astsaturov

This study identifies ANO6-mediated trogocytosis as a mechanism by which CAFs transfer lipids to PDAC cells, promoting tumor growth and immune suppression.

28 citationstop 1%

mouseproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 15, 2024

Netrin G1 Ligand is a new stromal immunomodulator that promotes pancreatic cancer

Debora Barbosa Vendramini Costa, Ralph Francescone, Janusz Franco‐Barraza…·Edna Cukierman

This paper identifies NGL-1 as a stromal immunomodulator in pancreatic cancer that promotes tumor growth by modulating the tumor microenvironment through TGF-β and transcription factor pathways.

3 citations

mousehuman

𝕏 PostBluesky